R ARIVANANTHAM
CHENNAI, JUNE 24
In a dramatic cardiac rescue that turned a near-fatal collapse into a story of recovery and renewed life, doctors at MGM Healthcare, Chennai, saved a 69-year-old man who suffered cardiogenic shock and cardiac arrest during an emergency angioplasty for a massive heart attack — using Extracorporeal Membrane Oxygenation (ECMO), an advanced artificial heart-and-lung support system, to keep him alive long enough for the blocked arteries to be reopened.
What makes the case extraordinary is not merely that the patient survived one of the most dangerous cardiovascular emergencies, but that he went on to regain heart function so significantly that follow-up tests showed a normal ejection fraction of 53% — a striking recovery for a man whose heart had briefly reached a state of complete standstill during the crisis.
- Chennai hospital combines emergency angioplasty with advanced heart-lung support to save a 69-year-old man who suffered cardiac arrest during treatment for a massive heart attack
- Patient, struck by severe STEMI, left main coronary blockage and cardiogenic shock, survived after doctors rapidly escalated support from IABP to ECMO in the cath lab
- MGM team restored blood flow through critically blocked coronary arteries using complex angioplasty and stent implantation after stabilising circulation with Extracorporeal Membrane Oxygenation
- From complete circulatory collapse and cardiac standstill to recovery of heart function with a normal ejection fraction of 53%, the case underscores the life-saving power of modern Mechanical Circulatory Support
- Doctors say advanced technologies such as ECMO and Impella are transforming outcomes for high-risk heart patients once considered too unstable for complex coronary intervention
The patient had been admitted with ST-Elevation Myocardial Infarction (STEMI), one of the most severe forms of heart attack. Doctors found critical blockages in the left main coronary artery and other major vessels supplying blood to the heart. His condition was already precarious because of cardiogenic shock, a life-threatening state in which the heart is unable to pump enough blood to sustain the body’s vital organs.
The situation worsened during the emergency angioplasty when the patient developed a dangerous heart rhythm disturbance, followed by cardiac arrest and profound circulatory collapse. Although the medical team immediately performed cardiopulmonary resuscitation (CPR) and restored his heartbeat, he remained critically unstable. Recognising that conventional support would not be enough, doctors quickly escalated treatment from an intra-aortic balloon pump (IABP) to ECMO, a far more powerful life-support technology capable of taking over much of the work of both the heart and lungs.
An IABP is a balloon-based device that supports the heart by rhythmically inflating and deflating inside the aorta, thereby improving blood flow to the coronary arteries and reducing the heart’s workload. But in patients with severe cardiogenic shock or cardiac arrest, support often needs to go much further. ECMO circulates blood outside the body through a machine that oxygenates it and pumps it back, providing near-complete circulatory support and preserving blood flow and oxygen delivery to vital organs when the heart can no longer do so effectively on its own.
Once circulation had been stabilised, the MGM team led by Dr Babu Ezhumalai proceeded with complex angioplasty and stent implantation, successfully restoring blood flow through the critically blocked coronary arteries. The patient subsequently required prolonged intensive care and multidisciplinary management, but he gradually improved, was successfully weaned off ECMO, regained mobility and was eventually discharged home in a stable condition.
The most remarkable part of the story unfolded in recovery. Follow-up evaluation showed that the patient’s heart function had rebounded from a state of complete standstill after cardiac arrest to a normal pumping capacity, with an ejection fraction of 53%, allowing him to return to an active daily life.
In his comments, Dr Babu Ezhumalai said,
“Modern heart care is undergoing a significant transformation with the increasing use of advanced Mechanical Circulatory Support (MCS) technologies during complex and high-risk coronary interventions. Devices such as Impella and Extracorporeal Membrane Oxygenation (ECMO) are helping doctors safely perform life-saving procedures in patients who, until recently, were often considered too sick or too high-risk for treatment. Many patients who were considered unsuitable for complex coronary intervention can now be treated successfully with modern circulatory support technologies. They increase both the survival and recovery rate of high-risk patients. Advanced Mechanical Circulatory Support (MCS) devices enable cardiologists to perform complex high-risk angioplasty in patients with severe coronary artery disease, poor heart function, cardiogenic shock, and other life-threatening conditions that previously carried a very poor prognosis. The benefits extend beyond survival alone. By restoring blood flow early and supporting circulation during critical periods, these technologies can allow the heart muscle to recover, resulting in significant improvement in cardiac function and quality of life.”
For MGM Healthcare, the case is a compelling demonstration of how speed, critical care coordination and access to advanced circulatory support can alter the trajectory of patients at the very edge of survival. For the 69-year-old patient, it marks something even greater — a return from the brink, powered by technology, expertise and a second chance that, only moments earlier, had seemed impossible.
